Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DGKA | P23743 | 1/20 | 0.66 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.65 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.65 |
| ▸ | TSHR | P16473 | 1/20 | 0.65 |
| ▸ | ATM | Q13315 | 1/20 | 0.65 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.63 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.63 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.63 |
| ▸ | PRKCA | P17252 | 1/20 | 0.63 |
| ▸ | LPAR1 | Q92633 | 8/20 | 0.59 |
| ▸ | ENPP2 | Q13822 | 4/20 | 0.59 |
| ▸ | LPAR3 | Q9UBY5 | 4/20 | 0.59 |
| ▸ | LPAR4 | Q99677 | 3/20 | 0.59 |
| ▸ | LPAR2 | Q9HBW0 | 3/20 | 0.59 |
| ▸ | LPAR5 | Q9H1C0 | 2/20 | 0.59 |
| ▸ | CES2 | O00748 | 1/20 | 0.59 |
| ▸ | LPAR6 | P43657 | 1/20 | 0.59 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.59 |
| ▸ | RECQL | P46063 | 1/20 | 0.56 |
| ▸ | BLM | P54132 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9933561 | 1.00 | DGKA (0.66) | DGKATDP1CYP3A4TSHRATM | |
| SCHEMBL20969290 | 1.00 | DGKA (0.66) | DGKATDP1CYP3A4TSHRATM | |
| SCHEMBL20969291 | 1.00 | DGKA (0.66) | DGKATDP1CYP3A4TSHRATM | |
| SCHEMBL8956548 | 1.00 | DGKA (0.66) | DGKATDP1CYP3A4TSHRATM | |
| SCHEMBL9933462 | 0.98 | DGKA (0.68) | DGKATDP1CYP3A4TSHRATM | |
| SCHEMBL3849574 | 0.98 | DGKA (0.68) | DGKATDP1CYP3A4TSHRATM | |
| SCHEMBL9933260 | 0.98 | DGKA (0.68) | DGKATDP1CYP3A4TSHRATM | |
| SCHEMBL10784004 | 0.98 | DGKA (0.68) | DGKATDP1CYP3A4TSHRATM | |
| SCHEMBL10784010 | 0.98 | DGKA (0.68) | DGKATDP1CYP3A4TSHRATM | |
| SCHEMBL8956657 | 0.98 | DGKA (0.68) | DGKATDP1CYP3A4TSHRATM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2051781-B1 | COSMETIC COMPOSITIONS CONTAINING ESTER OBTAINED FROM 2-BUTYL-1-OCTANOL | COGNIS IP MAN GMBH (DE) | 2015-12-02 | — | — | EP | claimed |
| US-20100298432-A1 | Cosmetic Compositions Containing Esters of 2-Butyloctanol | COGNIS IP MANAGEMENT GMBH (DE) | 2010-11-25 | — | — | US | claimed |
| EP-3913039-B1 | BLEND OF ESTER COMPOUNDS | KLUEBER LUBRICATION MUENCHEN SE & CO KG (DE) | 2024-01-31 | — | — | EP | disclosed |
| US-11795134-B2 | Ester compounds, method for the production thereof and use thereof | KLÜBER LUBRICATION MÜNCHEN SE & CO. KG (DE) | 2023-10-24 | — | — | US | disclosed |
| EP-3609988-B1 | USE OF ESTER COMPOSITION | KLUEBER LUBRICATION MUENCHEN SE & CO KG (DE) | 2023-06-07 | — | — | EP | disclosed |
| CN-110431218-B | Novel ester compound, process for producing the same, and use thereof | 慕尼黑克吕伯尔润滑器股份两合公司 | 2022-09-13 | — | — | CN | disclosed |
| EP-3913039-A1 | ESTER COMPOUNDS, METHOD FOR THEIR PREPARATION AND THEIR USE | Klüber Lubrication München SE & Co. KG (DE) | 2021-11-24 | — | — | EP | disclosed |
| US-20210061750-A1 | Novel Ester Compounds, Method for the Production Thereof and Use Thereof | KLUBER LUBRICATION MUNCHEN SE & Co. KG (DE) | 2021-03-04 | — | — | US | disclosed |
| US-10829436-B2 | Ester compounds, method for the production thereof and use thereof | KLÜBER LUBRICATION MÜNCHEN SE & CO. KG (DE) | 2020-11-10 | — | — | US | disclosed |
| US-20200140370-A1 | Novel Ester Compounds, Method for the Production Thereof and Use Thereof | UNIVERSITÄTSSTR BIELEFELD (DE) | 2020-05-07 | — | — | US | disclosed |
| EP-2550954-B1 | VASELINE-LIKE COMPOSITION, AND COSMETIC PREPARATION | NISSHIN OILLIO GROUP LTD (JP) | 2020-03-04 | — | — | EP | disclosed |
| US-20130005808-A1 | VASELINE-LIKE COMPOSITION AND COSMETIC | The Nisshin OilliO Group ,Ltd. (JP) | 2013-01-03 | — | — | US | disclosed |
| CN-102821743-A | Vaseline-like composition and cosmetic | NISSHIN OILLIO GROUP LTD | 2012-12-12 | — | — | CN | disclosed |
| EP-2494952-A1 | COMPOSITION FOR COSMETICS, COSMETIC, METHOD FOR PRODUCING OIL-IN-WATER EMULSION COSMETIC, AND TWO SEPARATE LAYER-TYPE COSMETIC | The Nisshin Oillio Group, Ltd. (JP) | 2012-09-05 | — | — | EP | disclosed |
| US-20120156271-A1 | COMPOSITION FOR COSMETICS, COSMETIC, METHOD FOR PRODUCING OIL-IN-WATER EMULSION COSMETIC, AND TWO SEPARATE LAYER-TYPE COSMETIC | THE NISSHIN OILLIO GROUP, LTD. (JP) | 2012-06-21 | — | — | US | disclosed |
| US-20100298432-A1 | Cosmetic Compositions Containing Esters of 2-Butyloctanol | COGNIS IP MANAGEMENT GMBH (DE) | 2010-11-25 | — | — | US | disclosed |
| EP-0623164-B1 | Use as hydraulic fluids of esterification products of oleic acid with 2-alkyl-1-alkanols | RWE DEA AG (DE) | 1996-01-03 | — | — | EP | disclosed |
| US-5474714-A | Esterification products of monounsaturated fatty acids and 2-alkyl-1-alkanols; biodegradability | RWE-DEA AKTIENGESELLSCHAFT FUR MINERALOEL UND CHEMIE (DE) | 1995-12-12 | — | — | US | disclosed |
| EP-0623164-A1 | HYDRAULIC FLUIDS. | RWE DEA AG (DE) | 1994-11-09 | — | — | EP | disclosed |
| WO-1993015167-A1 | HYDRAULIC FLUIDS | RWE-DEA AKTIENGESELLSCHAFT FÜR MINERALÖL UND CHEM IE (DE) | 1993-08-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10829436-B2 | Ester compounds, method for the production thereof and use thereof | CYP46A1, CYP51A1, CEL | DGKA 1051/4885TDP1 3922/4885CYP3A4 48/4885 |
| US-11795134-B2 | Ester compounds, method for the production thereof and use thereof | CYP46A1, CYP17A1, CYP51A1 | DGKA 1164/4885TDP1 3965/4885CYP3A4 38/4885 |
| US-20120156271-A1 | COMPOSITION FOR COSMETICS, COSMETIC, METHOD FOR PRODUCING OIL-IN-WATER EMULSION COSMETIC, AND TWO SEPARATE LAYER-TYPE COSMETIC | GK, DGKG, MGLL | DGKA 5/4885TDP1 3610/4885CYP3A4 4481/4885 |
| US-20210061750-A1 | Novel Ester Compounds, Method for the Production Thereof and Use Thereof | CYP46A1, CEL, CYP51A1 | DGKA 1078/4885TDP1 4019/4885CYP3A4 63/4885 |
| US-20200140370-A1 | Novel Ester Compounds, Method for the Production Thereof and Use Thereof | CYP46A1, CYP51A1, CEL | DGKA 1089/4885TDP1 4323/4885CYP3A4 65/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.